3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
32
Leukemia, Lymphocytic, Chronic, B-Cell
22
Myelodysplastic Syndromes
9
Lymphoma, Follicular
8
Neoplasms
7
Lymphoma, Non-Hodgkin
7
Lymphoma, Mantle-Cell
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Leukemia
6
Recurrence
5
Leukemia, Myelomonocytic, Chronic
5
Multiple Myeloma
4
Chromosome 17 deletion
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, B-Cell, Marginal Zone
3
Leukemia, Myeloid
3
Hematologic Neoplasms
3
Waldenstrom Macroglobulinemia
2
Lymphoma, B-Cell
2
Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Breast Neoplasms
2
Tumor Lysis Syndrome
1
Small Cell Lung Carcinoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Myeloid Malignancy
1
Myeloid Malignancies
1
Interventions
blinatumomab
6
Cyclophosphamide
5
Rituximab
4
Tacrolimus
3
ponatinib
2
fludarabine
2
denileukin diftitox
2
Vorinostat
2
Vincristine
2
Prednisone
2
Peripheral Blood Stem Cell Transplantation
2
Methotrexate
2
Everolimus
2
Etoposide
2
Doxorubicin
2
Darbepoetin alfa
2
Cytarabine
2
Busulfan
2
Brentuximab Vedotin
2
Antilymphocyte Serum
2
Alemtuzumab
2
tetulomab tetraxetan lu-177
1
ruxolitinib
1
pembrolizumab
1
pegaspargase
1
ibrutinib
1
ibritumomab tiuxetan
1
fludarabine phosphate
1
ferrous sulfate
1
ferric gluconate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoproliferative Disorders
×
venetoclax
×
Clear all
No trials found.